PT-141 (Bremelanotide)
A melanocortin-pathway peptide studied in neurobehavioral research.
Overview
PT-141, also known as Bremelanotide, is a synthetic peptide studied in research literature for its interactions with melanocortin receptors in the central nervous system. It is a commonly referenced compound in neurobehavioral and melanocortin-pathway research contexts.
Referenced research ranges
0.5–2 mg, as referenced in research, not daily — research protocols reference intermittent, event-based administration
Reconstitution default
10 mg in 2 mL yields 5 mg/mL; a 1 mg reference dose is 0.2 mL (20 units on a U-100 syringe).
Storage
Store lyophilized vials in a cool, dark place; refrigerate after reconstitution and protect from light.
Considerations
- Interacts with central melanocortin receptors rather than a peripheral tissue target.
- Research protocols reference intermittent rather than continuous administration.
- Reconstituted peptide is temperature-sensitive and light-sensitive.
Log doses, get reminders, and run the calculator in PepSensei.
PepSensei is an educational reference tool only. Nothing in this library is medical advice, and none of it is intended to diagnose, treat, cure, or prevent any condition. All figures — including dose ranges, half-lives, and reconstitution examples — are commonly-cited values drawn from published research literature and are provided strictly for reference and general education in a research context. They are not protocols, recommendations, or instructions. Always consult a licensed medical professional before making any decision related to your health.